Boenning & Scattergood’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$223K Sell
3,744
-525
-12% -$41.6K 0.04% 367
2022
Q3
$263K Hold
4,269
0.05% 309
2022
Q2
$264K Buy
4,269
+525
+14% +$32.5K 0.05% 313
2022
Q1
$223K Sell
3,744
-5,555
-60% -$355K 0.04% 367
2021
Q4
$675K Sell
9,299
-1,670
-15% -$115K 0.11% 212
2021
Q3
$766K Buy
10,969
+539
+5% +$37.9K 0.13% 182
2021
Q2
$718K Sell
10,430
-14,965
-59% -$999K 0.13% 182
2021
Q1
$1.64M Buy
25,395
+14,993
+144% +$967K 0.31% 90
2020
Q4
$606K Sell
10,402
-5,825
-36% -$351K 0.13% 177
2020
Q3
$1.02M Buy
16,227
+6,800
+72% +$472K 0.25% 103
2020
Q2
$725K Sell
9,427
-17,254
-65% -$1.32M 0.19% 126
2020
Q1
$2M Sell
26,681
-777
-3% -$53.7K 0.69% 36
2019
Q4
$1.78M Buy
27,458
+4,355
+19% +$284K 0.46% 54
2019
Q3
$1.46M Sell
23,103
-1,070
-4% -$69.9K 0.42% 62
2019
Q2
$1.63M Sell
24,173
-4,257
-15% -$280K 0.48% 58
2019
Q1
$1.85M Buy
28,430
+8,254
+41% +$549K 0.55% 47
2018
Q4
$1.26M Buy
20,176
+180
+0.9% +$12.6K 0.44% 58
2018
Q3
$1.54M Sell
19,996
-575
-3% -$43.4K 0.49% 51
2018
Q2
$1.46M Buy
+20,571
New +$1.45M 0.48% 60

Other funds holding GILD

Boenning & Scattergood's GILD Position: Q4 2022 in Review

Boenning & Scattergood reduced its Gilead Sciences (GILD) stake by 12% in Q4 2022, selling an estimated $41.6K and leaving 3,744 shares worth $223K. The position accounts for 0.04% of the portfolio, ranked #367.

Boenning & Scattergood first reported a position in GILD in Q2 2018 and has held it in 19 quarters since. The position peaked at $2M in Q1 2020. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Boenning & Scattergood held 3,744 shares of Gilead Sciences worth $223K as of Q4 2022.
  • Boenning & Scattergood sold 525 Gilead Sciences shares in Q4 2022, an estimated $41.6K.
  • Gilead Sciences made up 0.04% of Boenning & Scattergood's portfolio in Q4 2022, its #367 holding.
  • Boenning & Scattergood first reported a position in Gilead Sciences in Q2 2018 and has held it in 19 quarters since.
  • Boenning & Scattergood's Gilead Sciences position peaked at $2M in Q1 2020.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.